NASDAQ$MASS

908 Devices Inc · Q4 2023 earnings

Q4 2023 earnings · · Investor relations

Briefing

Reported a revenue increase driven by handheld revenue, but faced headwinds in life science instrumentation.

908 Devices reported a 23% increase in revenue for the fourth quarter of 2023, primarily driven by a 57% increase in handheld device revenue. The installed base grew, and recurring revenue represented 33% of total revenues. Despite near-term headwinds in the life science sector, the company launched two additional desktop devices.

  • Revenue increased by 23% compared to the prior year period.
  • Handheld devices revenue increased by 57% year-over-year.
  • The installed base grew to 2,853 devices with 139 devices placed during the quarter.
  • Net loss narrowed to $7.4 million, compared to $9.8 million in the prior year period.

Headline financials

Total Revenue

$14.4M

Previous: $11.6M+23.3%
EPS (adj)

-$0.23

Previous: -$0.31+25.8%
Capital Expenditures

$333K

Previous: $612K-45.6%
Net Income

-$7.4M

Previous: -$9.8M+24.5%
Operating Income

-$9.71M

Previous: -$10.4M+6.6%
Gross Profit

$7.28M

Previous: $5.9M+23.3%
R&D Expense

$5.44M

No prior period
Stock-Based Comp

$2.34M

Previous: $2M+16.7%

Revenue & EPS history

908 Devices · Revenue · Quarterly

$14.4M

Q4 2023+23.3%vs Q4 2022
Beat estimate in 12 of 15 quarters(80%)
ActualEstimate

Forward guidance

908 Devices expects full year 2024 revenue to be in the range of $52.0 million to $54.0 million, representing 4% to 8% growth over full year 2023.

Tailwinds

  • Full year 2024 revenue expected to be in the range of $52.0 million to $54.0 million.
  • Projected revenue growth of 4% to 8% over full year 2023.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2023

Historical avgQ4 2023

+1.3%

Avg return

Earnings day

-2.9%

Avg return

5 days after

+2.8%

Avg return

30 days after

46%

11 / 24 earnings

Positive

+96.0%

Q4 2024

Best reaction

-35.4%

Q3 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+13.7%+11.8%+11.8%
Q4 2025-4.8%-5.3%+0.0%
Q3 2025-13.2%-25.7%-10.8%
Q1 2025-18.9%-20.1%+25.5%
Q4 2024+96.0%+39.4%+88.9%
Q3 2024-35.4%-34.0%-41.4%
Q2 2024-5.0%-6.0%-21.6%
Q1 2024-1.4%-1.8%+7.0%
Q4 2023-1.1%-5.1%-10.1%
Q3 2023-4.9%-11.2%+23.0%
Q2 2023+17.7%+15.0%+8.1%
Q1 2023+8.4%+4.8%+28.6%
Q4 2022+0.3%-10.6%-5.5%
Q3 2022-34.4%-38.2%-44.4%
Q2 2022-8.9%-9.9%-7.6%
Q1 2022-12.6%+6.6%-5.5%
Q4 2021+12.8%+17.2%+24.7%
Q3 2021+14.7%+2.7%-30.0%
Q3 2020+14.7%+2.7%-30.0%
Q2 2021+9.4%+5.4%+26.2%
Q2 2020+9.4%+5.4%+26.2%
Q1 2021-16.3%-14.6%-7.3%
Q1 2020-16.3%-14.6%-7.3%
Q4 2020+7.8%+15.8%+18.0%
Q4 2019
Q3 2019
Q2 2019
Q1 2019

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro